531 related articles for article (PubMed ID: 18248491)
21. End-stage diabetic nephropathy. Discussion: technical aspects of dialysis.
Kidney Int Suppl; 1974 Oct; (1):115-28. PubMed ID: 4533906
[No Abstract] [Full Text] [Related]
22. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
[TBL] [Abstract][Full Text] [Related]
23. Diabetic nephropathy in patients with type 1 diabetes mellitus.
Russell TA
Nephrol Nurs J; 2006; 33(1):15-28; quiz 29-30. PubMed ID: 16538925
[TBL] [Abstract][Full Text] [Related]
24. Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy.
Ravera M; Re M; Vettoretti S
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S44-8. PubMed ID: 16565246
[TBL] [Abstract][Full Text] [Related]
25. [Antidiabetic agents and renal insufficiency].
Robles NR; Blanco J
Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
[No Abstract] [Full Text] [Related]
26. Dietary management of patients with diabetes treated by hemodialysis.
Davis M; Comty C; Shapiro F
J Am Diet Assoc; 1979 Sep; 75(3):265-9. PubMed ID: 469138
[TBL] [Abstract][Full Text] [Related]
27. [Organ transplantation in diabetics patients with ESRD].
Thervet E
Nephrol Ther; 2006 Jan; 2 Suppl 1():S63-5. PubMed ID: 17378143
[TBL] [Abstract][Full Text] [Related]
28. HLA-antigen distribution in juvenile diabetics with end-stage nephropathy.
Pitkänen E; Kuhlbäck B; Tiilikainen A; Lokki ML; Kärkkäinen J
Ann Clin Res; 1981 Apr; 13(2):91-5. PubMed ID: 7235615
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of diabetes mellitus in dialysis patients].
Bondar' IA; Klimontov VV
Ter Arkh; 2011; 83(12):73-7. PubMed ID: 22416450
[TBL] [Abstract][Full Text] [Related]
30. [Diabetes mellitus and chronic renal insufficiency].
Rychlík I; Sulková S
Vnitr Lek; 2003 May; 49(5):395-402. PubMed ID: 12908175
[TBL] [Abstract][Full Text] [Related]
31. [Chronic kidney disease and antidiabetic treatment].
Berwert L; Teta D; Zanchi A
Rev Med Suisse; 2007 Mar; 3(101):598-604. PubMed ID: 17436798
[TBL] [Abstract][Full Text] [Related]
32. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy.
Hasslacher C; Collenberg E; Möcks J
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):341-5. PubMed ID: 20112184
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
Pabico RC; Rivero AJ; McKenna BA; Freeman RB
Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
[TBL] [Abstract][Full Text] [Related]
35. Diabetic nephropathy 1985. Prevalence, type, paradoxical insulin behavior.
Gonzalez J; Fein PA; Alvis RC; Lauer A; LeBeau P; Zouabi M; Melendez O; Avram MM
Trans Am Soc Artif Intern Organs; 1985; 31():577-80. PubMed ID: 3837511
[No Abstract] [Full Text] [Related]
36. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
37. [How do we optimize the management of chronic renal failure?].
Laville M; Duru G
Therapie; 2001; 56(5):533-43. PubMed ID: 11806290
[TBL] [Abstract][Full Text] [Related]
38. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
[TBL] [Abstract][Full Text] [Related]
39. Managing diabetes in dialysis patients.
O'Toole SM; Fan SL; Yaqoob MM; Chowdhury TA
Postgrad Med J; 2012 Mar; 88(1037):160-6. PubMed ID: 22282737
[TBL] [Abstract][Full Text] [Related]
40. How can we improve prognosis in diabetic patients with end-stage renal disease?
Ritz E; Koch M; Fliser D; Schwenger V
Diabetes Care; 1999 Mar; 22 Suppl 2():B80-3. PubMed ID: 10097905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
